MarketPulse — Real-Time Financial News & Market Analysis

Latest News

8,879 articles
Mon, Mar 23
BenzingaBenzinga··Chris Katje

Congressman Dumps Warner Bros. Discovery Stock Despite 150% Gain Amid Merger Review

Rep. Pfluger sells Warner Bros. Discovery stock despite 150% annual gain amid DOJ review of Paramount-Skydance merger.
NFLXWBDParamount SkydanceWarner Bros. Discovery
GlobeNewswire Inc.GlobeNewswire Inc.··Faruqi & Faruqi, Llp

Coty Faces Securities Lawsuit Over Undisclosed Business Deterioration

Securities class action filed against $COTY for failing to disclose weakness in beauty and fragrance segments. Stock fell 22% following disappointing Q2 results and guidance withdrawal.
COTYstock declineearnings miss
The Motley FoolThe Motley Fool··Todd Shriber

Blue Owl Crisis Triggers BDC Selloff—But BIZD Offers Bargain for Risk-Tolerant Investors

VanEck BDC Income ETF down 12% in 2026 as private credit turmoil spreads. BDCs trade at steep discounts to book value, potentially presenting opportunity.
OBDCBIZDhigh-yield ETFprivate credit
BenzingaBenzinga··Not Specified

Outlook Therapeutics Launches Capital Raise Through Public Stock Offering

Outlook Therapeutics launches best-efforts public offering of stock and warrants with H.C. Wainwright as placement agent, subject to market conditions.
OTLKwarrantspublic offering
The Motley FoolThe Motley Fool··Eric Volkman

Grocery Outlet CEO's $1.7M Share Purchase Ignites 11% Stock Rally

Grocery Outlet CEO buys $1.7M in stock, doubling stake as company faces comparable sales decline and launches 36-store closure plan.
GOcomparable sales declineinsider buying
The Motley FoolThe Motley Fool··Emma Newbery

U.S. Stocks Surge on Iran De-escalation; Oil Plunge Fuels Rally

U.S. stocks rallied March 23 as Iran de-escalation signals sparked crude oil decline. S&P 500, Nasdaq, Dow each gained 1.15-1.38% on travel and industrial strength.
DALFICOAALNCLHFederal Reservemarket volatility
BenzingaBenzinga··Erica Kollmann

Earnings Deluge: Ondas, GameStop, PDD Signal Week of Strategic Shifts

Major companies report earnings this week, including Ondas (strong $375M revenue outlook), GameStop (CEO Cohen's strategy review), and PDD (Temu expansion costs) alongside Carnival, Beyond Meat, and others.
CCLPDDONDSTMCTMCWW+2revenue outlookQ4 results
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Inventiva to Report 2025 Results as MASH Drug Candidate Advances

Inventiva will release 2025 financial results March 30, 2026, while advancing lanifibranor in Phase 3 MASH trials.
IVAPhase 3 clinical trialfinancial results
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Inventiva to Report 2025 Results as MASH Drug Candidate Advances in Phase 3

Inventiva to release 2025 financial results March 30, 2026, as its lanifibranor MASH drug advances through Phase 3 clinical trials.
IVAPhase 3 clinical trialfinancial results
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Centerra Gold Submits 2025 Annual Report to SEC, Full Financials Now Public

Centerra Gold files 2025 annual Form 40-F with SEC, including audited financials and MD&A, accessible via EDGAR and SEDAR+.
CGAUannual reportSEC filing
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Weatherford Secures Denmark Contract as Q1 Earnings Call Set

Weatherford to discuss Q1 2026 results April 22, secured multi-year Denmark completions contract.
WFRDconference callQ1 2026 earnings
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Richtech Robotics Faces Securities Lawsuit Over Alleged Microsoft Partnership Fabrication

Rosen Law Firm sues Richtech Robotics for allegedly fabricating Microsoft partnership claims. Affected investors must secure counsel before April 3 lead plaintiff deadline.
RRsecurities class actionlead plaintiff deadline
The Motley FoolThe Motley Fool··David Jagielski, Cpa

BMY's 4.4% Dividend Masks Looming Patent Cliff Risks

Bristol Myers Squibb's attractive 4.4% dividend yield faces headwinds from major patent expirations on blockbuster drugs Eliquis and Opdivo.
BMYCELGrhealthcaredividend sustainability
The Motley FoolThe Motley Fool··Eric Trie

Forefront Analytics Nearly Doubles iShares ESG EM ETF Position to $16M Stake

Forefront Analytics expanded iShares ESG EM ETF stake to $16.07M, adding 165,743 shares. $ESGE appreciated 40% in past year, outperforming S&P 500 by 29 points.
VEAVWOHDVESGEESGD+1emerging marketsportfolio allocation
The Motley FoolThe Motley Fool··Parkev Tatevosian, Cfa

Super Micro's Stock Plummets 30% Amid Fresh Misconduct Allegations

Super Micro Computer stock crashed over 30% following new misconduct accusations. The decline comes amid SEC investigations, accounting scandals, and smuggling charges.
SMCISEC investigationstock crash
The Motley FoolThe Motley Fool··Parkev Tatevosian, Cfa

Micron's Supply Shortage Positions Chipmaker for Sustained Pricing Power

Micron reiterates demand exceeds supply, positioning the chipmaker for sustained pricing power and margin expansion amid ongoing semiconductor shortage.
MUsemiconductorMicron Technology
The Motley FoolThe Motley Fool··Parkev Tatevosian, Cfa

C3.ai Stock Plunges 36% YTD Amid CEO Departure and Competitive Pressures

C3.ai stock falls 36% YTD after former CEO's resignation amid intensifying competition in enterprise AI market.
AIstock declineCEO resignation
The Motley FoolThe Motley Fool··Parkev Tatevosian, Cfa

Figma Stock Plummets 37% in 2026: Opportunity or Red Flag for Investors?

Figma stock plunged 37% in 2026 despite maintaining above-average revenue growth, raising questions about whether current levels present a buying opportunity or reflect justified concerns about AI disruption.
FIGrevenue growthundervalued stocks
The Motley FoolThe Motley Fool··Parkev Tatevosian, Cfa

Hidden Value: One Stock's Contrarian Opportunity as Market Tumbles

Management-led stock offers contrarian value opportunity amid market decline, with six-year crisis track record supporting asymmetric return potential.
ROKUstock valuationinvestment opportunity
The Motley FoolThe Motley Fool··Parkev Tatevosian, Cfa

IBM Stock Stumbles on AI Concerns: Is the Dip a Buying Opportunity?

IBM stock declines as investors question AI competitiveness. The dip raises debate over whether valuation presents opportunity or justified caution about transformation execution.
IBMartificial intelligenceinvestment opportunity